Pharmaceutical giant Merck & Co. (MRK) has slashed more than 85 percent of the positions targeted for elimination under its 2013 restructuring plan, Gen News reported this morning. Merck has eliminated “approximately 7,290 positions” since the restructuring plan was announced, the company said in its 10-Qc filing. The positions include full-time employees, independent contractors and … Continue reading
Merck job cuts mean the drugmaker is slashing about 20 percent of its workforce. 8,500 jobs will be added to the 7,500 Merck job cuts already announced, bringing the total to 16,000. Continue reading
Merck & Co, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, on Tuesday said it plans to cut annual operating costs by $2.5 billion and eliminate 8,500 jobs. Merck, whose shares rose 2.2 percent, said it aims to narrow its focus to products with the best chance of winning … Continue reading
The job losses at biotech firm Merck Serono were part of a wider restructuring plan “to create a leaner, more agile organisation,” the company said in a statement. “The planned measures for Merck Serono’s operations in Switzerland are needed to ensure our global competitive position in a rapidly changing market and to secure the long-term … Continue reading
German drugs and chemicals group Merck KGaA announced plans on Friday for a cost-cutting programme across all its businesses that may include job cuts. “Over the next two years Merck needs to address unprecedented market shifts, increasing competition in key product areas and existing inefficiencies in its own organization to ensure the long-term success of … Continue reading